[Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D007612:Kanamycin / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D010879:Piperazines / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology*; D014397:Tuberculosis, Pulmonary / Q000382:microbiology; D014756:Viomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D010879:Piperazines; D007612:Kanamycin; D012293:Rifampin; D014756:Viomycin